Park Compounding Pharmacy

info@parkcompounding.com

(855) 876-3060 Mon-Fri: 8:00am - 5:00pm

New Research on LDN for Dermatological Conditions

It seems like every month, new clinical trial results are published that demonstrate the effectiveness of low dose naltrexone for a variety of dermatological conditions. While LDN is being studied for treating everything from cervical cancer to arthritis, the field where some of the most conclusive results are being found is dermatology. Research published this […]

Low Dose Naltrexone Dosage

Low dose naltrexone is used to treat a variety of chronic conditions that often do not respond to other treatments. The drug has been getting a lot of attention lately from both prescribers and patients due to its demonstrated efficacy and safety and also its low monthly cost. However there is a lot of misinformation […]

Low Dose Naltrexone for Pain

The management of chronic pain in most cases involves the prescribing of opioids or non-steroidal anti-inflammatory drugs. These classes of drugs often have undesirable adverse effects and drug interactions. There is a significant need to find ways to treat pain that have less adverse effects and less risk of addiction. A promising treatment for pain […]

Compounded Treatments for Ulcerative Colitis

Ulcerative colitis is a chronic, inflammatory bowel disease that can be managed well with lifestyle changes and medication. Although the exact causes of the condition are not known, it is often associated with a recent infection from certain types of bacteria. The treatment for ulcerative colitis can involve a variety of medications meant to induce […]

LDN for Dermatological Conditions

It seems that new research demonstrating the benefits of daily low dose naltrexone (LDN) usage is published every month. Recently there have been case studies and reports showing that LDN may an effective treatment for dermatological conditions. A majority of existing treatments for these conditions are topical, making LDN a unique oral option that is […]

Integrative Medicine and Compounding

Integrative medicine developed as a way for physicians to combine different medical philosophies into one comprehensive medical practice. While there is debate as to what constitutes “alternative” or “conventional” medicine, integrative medicine generally seeks to combine accepted treatments with those that are not as well-studied. Integrative medicine’s goal is to provide medical treatments that consider […]

Low Dose Naltrexone for Inflammatory Bowel Disease

Many chronic conditions can potentially benefit from the use of low dose naltrexone (LDN). We have already discussed some of these applications on our blog including psoriasis and rheumatoid arthritis. Recent studies have found positive results when LDN is used to treat inflammatory bowel disease (IBD). For many patients, current treatments for IBD do not […]

Naltrexone for Weight Loss

A recently approved drug for weight loss called Contrave contains 8mg of the drug naltrexone combined with 90mg of bupropion (marketed on its own as Wellbutrin). Naltrexone was first approved in a dose of 50mg per day for helping opioid and alcohol addicts improve their chances of getting sober. The lower doses were proposed later […]

Low Dose Naltrexone for Psoriasis

Currently there is no cure for psoriasis and treatment involves preventing and reducing the extent of flare-ups. Low dose naltrexone is a promising new treatment option for psoriasis. This non-toxic drug has been prescribed for many years to treat a variety of chronic conditions. Medications Available for Treating Psoriasis Commercially available medications for treating psoriasis […]

LDN for Rheumatoid Arthritis

Low dose naltrexone (LDN) is a treatment that is being studied for a variety of chronic conditions that affect inflammatory processes in the body. One chronic condition that LDN is being used to treat is rheumatoid arthritis, which affects more than 1.3 million Americans. While the clinical research for this particular application is preliminary, patients […]